Jay Varkey
Overview
Jay Varkey, MD received his BA from Marquette University and an AOA graduate of the Medical College of Wisconsin. He completed his residency in Internal Medicine and Fellowship in Infectious Diseases at Duke University Medical Center, where he was a member of the Antimicrobial Evaluation Team and the Infection Control and Epidemiology Committee.
He was recruited to Emory University in 2009 to become the Director of the Antimicrobial Management Program and Associate Hospital Epidemiologist at Emory University Hospital (EUH). He also serves as the Co-Director of the Outpatient Parenteral Antimicrobial Treatment Clinic at Emory and as the Hospital Epidemiologist at the Wesley Woods Geriatric Hospital of Emory University.
Dr. Varkey currently serves on numerous institutional committees including the Department of Medicine Quality Council, the Department of Surgery Wound Infection Group, the Clinical Effectiveness Septicemia Design Team, and the Infectious Diseases Fellowship Program Admissions Committee.
Dr. Varkeys research interests are focused on the appropriate use of antimicrobials, reducing drug toxicities, reducing antimicrobial resistance, and improving patient outcomes. He was the recipient of a NIH KL2 award to study trends in antibiotic resistance in intensive care units using unit-specific antibiograms.
He is a member of the Data Safety Monitoring Board for an influenza vaccine trial. He has published 9 peer reviewed articles, four review articles and one book chapter. He is an active teacher and lecturer. He is the Co-Director of the Clinical Infectious Diseases Elective for 2nd year medical students.
Dr. Varkey was the recipient of the Department of Medicine Quality Achievement Award in 2012. He is a member of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America and the American Society of Transplantation, Infectious Diseases Community of Practice.
Academic Appointment
- Associate Professor of Medicine, Emory University School of Medicine
- Senior Physician, Emory University School of Medicine
Education
Degrees
- MD from Medical College of Wisconsin
- MD from Marquette University
Research
Focus
- My research is focused on identifying ways to increase the appropriate use of antimicrobials, decrease drug toxicity, reduce the emergence of antimicrobial resistance, reduce costs, and improve patient outcomes.
Publications
-
A bacteriophage-based validation of a personal protective equipment doffing procedure to be used with high-consequence pathogens.
Infect Control Hosp Epidemiol Volume: 45 Page(s): 1 - 7
05/06/2024 Authors: Berryhill BA; Burke KB; Smith AP; Morgan JS; Tarabay J; Mamora J; Varkey JB; Mumma JM; Kraft CS -
The potential risks of Legionella arising from ligature-resistant fixtures.
Am J Infect Control Volume: 52 Page(s): 344 - 348
03/01/2024 Authors: Tarabay J; Varkey JB -
Reductions in positive Clostridioides difficile events reportable to National Healthcare Safety Network (NHSN) with adoption of reflex enzyme immunoassay (EIA) testing in 13 Atlanta hospitals.
Infect Control Hosp Epidemiol Volume: 43 Page(s): 935 - 938
07/01/2022 Authors: Goodenough D; Sefton S; Overton E; Smith E; Kraft CS; Varkey JB; Fridkin SK -
SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients.
N Engl J Med Volume: 386 Page(s): 2436 - 2438
06/23/2022 Authors: Scherer EM; Babiker A; Adelman MW; Allman B; Key A; Kleinhenz JM; Langsjoen RM; Nguyen P-V; Onyechi I; Sherman JD -
Retinopathy and Systemic Disease Morbidity in Severe COVID-19.
Ocul Immunol Inflamm Volume: 29 Page(s): 743 - 750
05/19/2021 Authors: Shantha JG; Auld SC; Anthony C; Ward L; Adelman MW; Maier CL; Price KW; Jacob JT; Fashina T; Randleman C -
STOP-BSI: Reducing Methicillin-Resistant Staphylococcus aureus Bloodstream Infections in Oncology Patients
Volume: 41 Page(s): S391 - S391
10/01/2020 Authors: Yun M; Varkey J; Spinke R; Ayers M; Bell C; Bracewell E; Crabtree P; Holder C; Kaplow R; Whitson M -
Admission Screening for Clostridium difficile Infection (CDI) in Bone Marrow Transplant Populations
Volume: 41 Page(s): S113 - S113
10/01/2020 Authors: Tarabay J; Varkey J; Ayers M; Soni T; Langston A; Bracewell E; Bell C; Crain M; Hutcherson D; Smiley M -
Standardized Antimicrobial Administration Ratio (SAAR) Clinical Outcomes Assessment in a Large Community Healthcare System
Volume: 41 Page(s): S391 - S391
10/01/2020 Authors: Yun M; Varkey J; Spinke R; Ayers M; Bell C; Bracewell E; Crabtree P; Holder C; Kaplow R; Whitson M -
Admission Screening for Candida auris Among High-Risk Patient Populations
Volume: 41 Page(s): S113 - S113
10/01/2020 Authors: Tarabay J; Varkey J; Ayers M; Soni T; Langston A; Bracewell E; Bell C; Crain M; Hutcherson D; Smiley M -
Reductions in Positive Clostridioides difficile Events Reportable to NHSN With Adoption of Reflex EIA Testing in 13 Atlanta Hospitals
Volume: 41 Page(s): S47 - S48
10/01/2020 Authors: Goodenough D; Sefton S; Overton E; Smith E; Kraft C; Varkey J; Fridkin S